The post-transcriptional regulation of RyR2 mediated by the miR-106b-25 cluster could be a potential target for future gene therapy, since its loss would promote paroxysmal AF by the potentially arrhythmogenic Ca2+ leakage in the sarcoplasmic reticulum [203]. Here, RYR2 is linked to Paroxysmal atrial fibrillation.